Tech Company Financing Transactions
Aminex Therapeutics Funding Round
Aminex Therapeutics closed a $8.3 million funding round on 6/2/2018. Backers included private investors.
Transaction Overview
Company Name
Announced On
6/2/2018
Transaction Type
Venture Equity
Amount
$8,253,117
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 96 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
11335 NE 122nd Way 105
Kirkland, WA 98034
USA
Kirkland, WA 98034
USA
Phone
Website
Email Address
Not Recorded
Overview
Aminex Therapeutics, Inc., is a drug development company focused on discovery, development, and commercialization of a new subclass of cancer immunotherapies known as suppressor cell modulators (SCMs).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jim Skaggs
Chief Operating Officer
Tom Graham
Chief Scientific Officer
Mark Burns
Vice President
Michael Palfreyman
Browse more venture capital transactions:
Prev: 6/2/2018: CAST venture capital transaction
Next: 6/3/2018: QuarkChain venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. All VC database entries on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs